An interventional study of NEMOST V2 growing domino in Scoliosis Neuromuscular, Scoliosis Idiopathic and Consent Forms, sponsored by EUROS. Recruiting at 5 sites in France. Open to participants aged 5 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-02-11.
Sponsored by EUROS · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Scoliosis with a site in France — 18 open to participants now, 20 under way, 1 of them phase 3. Scoliosis · France.
Among the 57 studies in Scoliosis with a site in France, this one is the 6th largest by planned enrollment of the 25 interventional ones that give a count, is one of 5 that started in 2025, is one of 24 with no phase, reaches primary completion later than 19 of the 19 other live ones, and was the 53rd registered.
660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.
Browse Scoliosis studies →18 of the 57 studies in Scoliosis with a site in France are open now. Recruiting first, the newest first:
University Hospital, Montpellier · Sites in France
Ages 10–20
Hospices Civils de Lyon · Sites in France
Ages 11–17
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française · Sites in France
Ages 11–18 · Healthy volunteers
University Hospital, Limoges · Sites in France
Ages 8–16
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages 5+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.
This study: 5 Years to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 5 started in 2025.
This study's planned enrollment of 140 is above the median of 45 across 386 interventional studies indexed under Scoliosis.
Median enrollment 60 across the 25 interventional studies, 84 across the 32 observational. Of the 28 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 57 have an industry lead sponsor. The 10 most frequent:
EUROS is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
EUROS has 1 study filed under Scoliosis — fewer than ten, so there is no comparison to draw.
3 of the studies in Scoliosis with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07135765Assistance Publique - Hôpitaux de ParisParavertebral Muscles Assessment Using High-resolution MRI in Idiopathic or Neuromuscular Scoliosis Children | 2027-08 |
| NCT07356999Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge FrançaiseCharacterization of Visual Perception Impairments in Patients With Idiopathic Scoliosis | 2027-09-01 |
| NCT07421752Centre Hospitalier Universitaire, AmiensEvaluation of the Accuracy of the eCential Robotics Robot in Spinal Surgery | 2027-11 |
Add all 3 to your calendar (.ics) → With an account.
Among the 57 studies in Scoliosis with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.
As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.
Retrospective and prospective multicenter post-market surveillance clinical study.
This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.
The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.
The study will include 140 patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: NEMOST V2 growing domino
The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.
Complication rate
The safety of the device will be studied by monitoring all complications, reinterventions and revisions.
Time frame: 5 years
Cobb angle (°)
Comparison between preoperative measures, immediate postoperative measures and each visit measures. Measured on seated or standing anteroposterior and lateral X-ray images by identifying the most tilted vertebrae at the top and bottom of the spinal curve, drawing lines along their endplates, and calculating the angle formed by the intersection of perpendiculars to these lines. Normal value for Cobb angle is \<10° for no or benign scoliosis, medium scoliosis is defined between 15 and 35°, important scoliosis is defined as between 35 and 60° and very important scoliosis corresponds to angle \> 65°. The Cobb angle correction, used to compare pre and postoperative angle is defined as 100\*(preoperative value - postoperative value) / postoperative value.
Time frame: 5 years
Early-Onset Scoliosis questionnaire 24 items (EOSQ-24)
Considering clinical evaluation, the EOSQ-24 auto questionnaire addressed to patients' parents was selected. The 24-Item Early-onset Scoliosis Questionnaire (EOSQ-24) is a locally validated measurement tool to evaluate the overall impact of early onset scoliosis on patients' physical, psychological, and socio-economic well-being. Clinical results are assessed thanks to the EOSQ-24 quality of life questionnaire. It is divided in 11 themes, for which a score is calculated over 100. Each item is composed of 1 to 5 questions rated from 1 to 5, 5 being the best score. These scores will be between 0 to 100. Comparison between preoperative measures, immediate postoperative measures and each visit measures.
Time frame: 5 years
Pelvic obliquity (°)
Measured on seated or standing anteroposterior and lateral X-ray images by drawing a line between the iliac crests (or the inferior aspects of the sacroiliac joints) and calculating the angle between this line and a horizontal reference line. Normal value is 0°. Comparison between preoperative measures, immediate postoperative measures and each visit measures.
Time frame: 5 years
Thoracic kyphosis (°)
Measured on seated or standing anteroposterior and lateral X-ray images by calculating the Cobb angle between the superior endplate of the upper thoracic vertebra and the inferior endplate of the lower thoracic vertebra defining the kyphotic curve (commonly T4-T12). Comparison between preoperative measures, immediate postoperative measures and each visit measures.
Time frame: 5 years
Lumbar lordosis (°)
Measured on seated or standing anteroposterior and lateral X-ray images by calculating the Cobb angle between the superior endplate of the upper lumbar vertebra and the superior endplate of the sacrum (commonly L1-S1). Comparison between preoperative measures, immediate postoperative measures and each visit measures. Normal value ranges from 20 to 60°.
Time frame: 5 years
T1-T12 and T1-S1 length (mm)
T1-T12 length is measured on a standing or seated anteroposterior spinal radiograph as the linear distance between the midpoint of the superior endplate of T1 and the midpoint of the inferior endplate of T12. T1-S1 length is measured on a standing or seated anteroposterior spinal radiograph as the linear distance between the midpoint of the superior endplate of T1 and the midpoint of the superior endplate of S1. Comparison between preoperative measures, immediate postoperative measures and each visit measures.
Time frame: 5 years
Respiratory functional exploration
Pulmonary function testing is performed in a seated or supine position by measuring Total Lung Capacity (TLC, mL) and Vital Capacity (VC, mL) using standardized pulmonary function tests. Comparison between preoperative measures and each visit measures.
Time frame: 5 years
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Dec 2025 (actual). Primary completion is estimated for Dec 2033, 96 months after the start.
Of 234 interventional studies with no phase under Scoliosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 60. This study's planned 96 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
EUROS